Blood Transfusion Research Today is a free monthly online journal that collates and summarizes the latest research about Blood Transfusion, including details on blood donation, blood types, leukemia.

Volume 4 (2007), Issue 9 (September)

1. Efficacy and safety of epoetin alfa in critically ill patients.
   N Engl J Med, 357(10): 965-76. [Abstract] [Full-text]
2. RBC alloimmunization in blood transfusion-dependent beta-thalassemia patients in southern Iran.
   Int J Lab Hematol, 29(5): 321-6. [Abstract] [Full-text]
3. Incidence of transfusion-induced platelet-reactive antibodies evaluated by specific assays for the detection of human leucocyte antigen and human platelet antigen antibodies.
   Vox Sang, 93(3): 241-9. [Abstract] [Full-text]
4. Treatment of inherited protein C deficiency by replacement therapy with the French purified plasma-derived protein C concentrate (PROTEXEL).
   Vox Sang, 93(3): 233-40. [Abstract] [Full-text]
5. Where and when is blood transfused? An observational study of the timing and location of red cell transfusions in the north of England.
   Vox Sang, 93(3): 229-32. [Abstract] [Full-text]
6. Why have meta-analyses of randomized controlled trials of the association between non-white-blood-cell-reduced allogeneic blood transfusion and postoperative infection produced discordant results?
   Vox Sang, 93(3): 196-207. [Abstract] [Full-text]
7. Transfusion-associated microchimerism.
   Vox Sang, 93(3): 188-95. [Abstract] [Full-text]
8. Human leukocyte antigen may predict outcome of primary recurrent spontaneous abortion treated with paternal lymphocyte alloimmunization therapy.
   Am J Reprod Immunol, 58(4): 383-7. [Abstract] [Full-text]
9. Tranexamic acid diminishes intraoperative blood loss and transfusion in spinal fusions for duchenne muscular dystrophy scoliosis.
   Spine, 32(20): 2278-83. [Abstract] [Full-text]
10. Prognostic significance of early lymphocyte recovery after post-autografting administration of GM-CSF in non-Hodgkin's lymphoma.
    Bone Marrow Transplant, 40(7): 671-5. [Abstract] [Full-text]
11. Leukocyte reduction's role in the attenuation of infection risks among transfusion recipients.
    Clin Infect Dis, 45(8): 1008-13. [Abstract] [Full-text]
12. Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review.
    Transfusion, 47(10): 1919-29. [Abstract] [Full-text]
13. Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia.
    Transfusion, 47(10): 1830-6. [Abstract] [Full-text]
14. Clinical and economic burden of infused iron chelation therapy in the United States.
    Transfusion, 47(10): 1820-9. [Abstract] [Full-text]
15. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
    Transfusion, 47(10): 1809-15. [Abstract] [Full-text]
16. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
    Transfusion, 47(10): 1803-8. [Abstract] [Full-text]
17. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay.
    Transfusion, 47(10): 1794-802. [Abstract] [Full-text]
18. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA.
    Transfusion, 47(10): 1783-93. [Abstract] [Full-text]
19. Molecular mechanism underlying B19 virus inactivation and comparison to other parvoviruses.
    Transfusion, 47(10): 1765-74. [Abstract] [Full-text]
20. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay.
    Transfusion, 47(10): 1756-64. [Abstract] [Full-text]
21. Effects of endogenous ascorbate on oxidation, oxygenation, and toxicokinetics of cell-free modified hemoglobin after exchange transfusion in rat and guinea pig.
    J Pharmacol Exp Ther, 323(1): 49-60. [Abstract] [Full-text]
22. Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells.
    Blood, 110(7): 2736-43. [Abstract] [Full-text]
23. Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone.
    Blood, 110(7): 2761-3. [Abstract] [Full-text]
24. Transfusion practice in coronary artery bypass surgery in Denmark: a multicenter audit.
    Interact Cardiovasc Thorac Surg, 6(5): 623-7. [Abstract] [Full-text]
25. Acute plateletpheresis and aprotinin reduces the need for blood transfusion following Ross operation.
    Interact Cardiovasc Thorac Surg, 6(5): 618-22. [Abstract] [Full-text]

© 2004-2008 Blood Transfusion Research Today. All Rights Reserved.